Transgene SA Sustainability Reports

Transgene S.A. is a biotechnology company focused on designing and developing virus-based immunotherapies for the treatment of cancer. The company utilizes specialized technology platforms to engineer personalized therapeutic vaccines and oncolytic viruses intended to stimulate a patient's immune system against cancer cells.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 969500PDJW8N0FSGGK69

FIGI: BBG001S99KH5

13 reports from 2014 to 2025

• Transgene SA 2025 Universal Registration Document Including the Annual Financial Report
• Transgene SA 2024 Universal Registration Document Including the Annual Financial Report
• Transgene SA 2023 Universal Registration Document
• Transgene SA 2022 Universal Registration Document
• Transgene SA 2021 Universal Registration Document